Kevin L. Gardner, MD, PhD, has been named senior vice chair of the Department of Pathology and Cell Biology and professor of pathology and cell biology at CUMC. “Dr. Gardner’s mission at Columbia University is to expand his groundbreaking research on breast cancer pathogenesis and to help lead our precision medicine initiatives, particularly in underrepresented […]
Nearly 50 years after the “war on cancer” was declared in the United States, precision medicine is changing the face of cancer research.
At a special event at Columbia, oncologists and scientists will discuss how new research is changing the way cancer is being treated.
Advances in how the immune system can be harnessed to fight cancer offer new hope to patients with lung cancer.
Director of the National Cancer Institute, Harold Varmus, MD'66, talked about the challenges and goals of precision medicine's efforts to tackle cancer.
Andrea Califano discusses the potential for precision medicine to target differences in the ways disease presents in individuals.